Hanmi Pharm. Co., Ltd. (KRX:128940)
472,000
-2,000 (-0.42%)
Last updated: Nov 18, 2025, 10:48 AM KST
Hanmi Pharm. Market Cap
Hanmi Pharm. has a market cap or net worth of 5.85 trillion as of November 18, 2025. Its market cap has increased by 38.44% in one year.
Market Cap
5.85T
Enterprise Value
6.25T
Revenue
1.50T
Ranking
n/a
PE Ratio
44.38
Stock Price
472,000.00
Market Cap Chart
Since July 30, 2010, Hanmi Pharm.'s market cap has increased from 680.70B to 5.85T, an increase of 758.76%. That is a compound annual growth rate of 15.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2025 | 5.85T | 64.35% |
| Dec 30, 2024 | 3.56T | -20.49% |
| Dec 28, 2023 | 4.47T | 20.54% |
| Dec 29, 2022 | 3.71T | 10.00% |
| Dec 30, 2021 | 3.37T | -23.27% |
| Dec 30, 2020 | 4.40T | 25.97% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 86.90T |
| Celltrion | 40.49T |
| ALTEOGEN | 29.90T |
| SK Biopharmaceuticals | 9.93T |
| ABL Bio | 9.18T |
| Yuhan | 8.97T |
| Peptron | 7.28T |
| HLB Co., Ltd. | 6.53T |